Royal Bank of Canada
RVMD icon

Royal Bank of Canada’s Revolution Medicines RVMD Stock Holding History

Royal Bank of Canada’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.4M Sell
226,210
-145,533
-39% -$21.3M 0.01% 1094
2026
Q1 		$36.2M Sell
371,743
-131,978
-26% -$13.3M 0.01% 1087
2025
Q4 		$40.1M Buy
503,721
+311,392
+162% +$20.4M 0.01% 1062
2025
Q3 		$8.98M Buy
192,329
+106,158
+123% +$4.16M ﹤0.01% 2228
2025
Q2 		$3.17M Buy
86,171
+83,746
+3,453% +$3.22M ﹤0.01% 2940
2025
Q1 		$86K Sell
2,425
-9,401
-79% -$382K ﹤0.01% 5309
2024
Q4 		$518K Sell
11,826
-18,114
-61% -$914K ﹤0.01% 4066
2024
Q3 		$1.36M Buy
29,940
+13,343
+80% +$581K ﹤0.01% 3288
2024
Q2 		$644K Buy
16,597
+10,206
+160% +$381K ﹤0.01% 3812
2024
Q1 		$205K Sell
6,391
-39,172
-86% -$1.16M ﹤0.01% 4669
2023
Q4 		$1.31M Buy
45,563
+30,664
+206% +$737K ﹤0.01% 3450
2023
Q3 		$413K Buy
14,899
+6,404
+75% +$190K ﹤0.01% 4206
2023
Q2 		$227K Buy
8,495
+3,392
+66% +$83.2K ﹤0.01% 4627
2023
Q1 		$110K Sell
5,103
-4,715
-48% -$116K ﹤0.01% 5110
2022
Q4 		$234K Buy
9,818
+8,710
+786% +$185K ﹤0.01% 4743
2022
Q3 		$22K Buy
1,108
+553
+100% +$12.2K ﹤0.01% 6105
2022
Q2 		$11K Sell
555
-3,295
-86% -$64.1K ﹤0.01% 6352
2022
Q1 		$98K Buy
3,850
+530
+16% +$11.5K ﹤0.01% 5662
2021
Q4 		$84K Buy
3,320
+1,565
+89% +$44.1K ﹤0.01% 6061
2021
Q3 		$48K Buy
+1,755
New +$51.1K ﹤0.01% 6191
2021
Q2 		– Sell
-2,994
Closed -$137K – 7651
2021
Q1 		$137K Buy
2,994
+2,498
+504% +$112K ﹤0.01% 5225
2020
Q4 		$20K Buy
496
+466
+1,553% +$18.4K ﹤0.01% 6071
2020
Q3 		$1K Buy
30
+5
+20% +$138 ﹤0.01% 6472
2020
Q2 		$1K Sell
25
-683
-96% -$21.5K ﹤0.01% 6475
2020
Q1 		$15K Buy
+708
New +$19.6K ﹤0.01% 5676

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Royal Bank of Canada's RVMD Position: Q2 2026 in Review

Royal Bank of Canada reduced its Revolution Medicines (RVMD) stake by 39% in Q2 2026, selling an estimated $21.3M and leaving 226,210 shares worth $42.4M. The position accounts for 0.01% of the portfolio, ranked #1094.

Royal Bank of Canada first reported a position in RVMD in Q1 2020 and has held it in 25 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Royal Bank of Canada held 226,210 shares of Revolution Medicines worth $42.4M as of Q2 2026.
  • Royal Bank of Canada sold 145,533 Revolution Medicines shares in Q2 2026, an estimated $21.3M.
  • Revolution Medicines made up 0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #1094 holding.
  • Royal Bank of Canada first reported a position in Revolution Medicines in Q1 2020 and has held it in 25 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.